Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-20

Clinical Trial Update: Using MASL to Combat Oral Cancer [EARLY_Phase 1]

View source ↗

Summary

This update reports the completion and posted results of an early-phase 1 clinical trial evaluating MASL for head and neck squamous cell carcinoma (oral cancer)…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MASL

Snippet

Sponsor: Rowan University | Conditions: Squamous Cell Carcinoma of Head and Neck | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2026-03-20